Table 4.
Component | Lipoprotein Component | General Parameter | r | P |
---|---|---|---|---|
Lipids | Extra-large HDL* | M-value* | 0.49 | <0.001 |
Extra-large HDL* | ALAT* | −0.38 | 0.01 | |
Extra-large HDL* | Liver volume* | −0.50 | <0.001 | |
Small HDL | M-value* | −0.46 | <0.001 | |
Small HDL | V̇o2peak | −0.37 | 0.01 | |
Small HDL | LFC† | 0.35 | 0.02 | |
Small HDL | Liver volume* | 0.36 | 0.01 | |
Phospholipids | Extra-large HDL† | M-value* | 0.35 | 0.01 |
Extra-large HDL† | Liver volume* | −0.39 | <0.001 | |
Small HDL* | M-value* | −0.59 | <0.001 | |
Small HDL* | V̇o2peak | −0.54 | <0.001 | |
Small HDL* | LFC† | 0.50 | <0.001 | |
Small HDL* | Liver volume* | 0.46 | <0.001 | |
Cholesterol | Extra-large HDL* | M-value* | 0.42 | <0.01 |
Extra-large HDL* | ALAT* | −0.37 | 0.01 | |
Extra-large HDL* | Liver volume* | −0.43 | <0.001 | |
Cholesterol esters | Extra-large HDL* | Liver volume* | −0.29 | 0.03 |
Free cholesterol | Extra-large HDL* | M-value* | 0.44 | <0.01 |
Extra-large HDL* | ALAT* | −0.29 | 0.03 | |
Extra-large HDL* | Liver volume* | −0.44 | <0.001 | |
Small HDL* | M-value* | −0.50 | <0.001 | |
Small HDL* | LFC† | 0.41 | 0.01 | |
Small HDL* | Liver volume* | 0.40 | <0.01 | |
Triglycerides | Small HDL* | M-value* | −0.66 | <0.001 |
Small HDL* | V̇o2peak | −0.42 | <0.001 | |
Small HDL* | ALAT* | 0.41 | <0.001 | |
Small HDL* | LFC† | 0.54 | <0.001 | |
Small HDL* | Liver volume* | 0.52 | <0.001 |
Number of subjects n = 44 (all men). Women were excluded from the analysis to avoid mixing effects of sex. ALAT, alanine transaminase; HDL, high-density lipoprotein; LFC, liver fat content; M-value, whole body insulin sensitivity; V̇o2peak, aerobic capacity (peak oxygen consumption).
Log transformation was performed to achieve normal distribution.
Square root transformation was performed to achieve normal distribution.